Gauthier LV, Taub E, Mark VW, Barghi A, Uswatte G Atrophy of spared gray matter tissue predicts poorer motor recovery and rehabilitation response in chronic stroke. Stroke. 2012 Feb;43(2):453-7. doi: 10.1161/STROKEAHA.111.633255.
Grefkes C, Eickhoff SB, Nowak DA, Dafotakis M, Fink GR Dynamic intra- and interhemispheric interactions during unilateral and bilateral hand movements assessed with fMRI and DCM. Neuroimage. 2008 Jul 15;41(4):1382-94. doi: 10.1016/j.neuroimage.2008.03.048.
Jones SE, Buchbinder BR, Aharon I Three-dimensional mapping of cortical thickness using Laplace's equation. Hum Brain Mapp. 2000 Sep;11(1):12-32.
Kolb B Recovery from early cortical damage in rats. I. Differential behavioral and anatomical effects of frontal lesions at different ages of neural maturation. Behav Brain Res. 1987 Sep;25(3):205-20.
Mori S, Crain BJ, Chacko VP, van Zijl PC Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol. 1999 Feb;45(2):265-9.
Pierpaoli C, Basser PJ Toward a quantitative assessment of diffusion anisotropy. Magn Reson Med. 1996 Dec;36(6):893-906. Erratum in: Magn Reson Med 1997 Jun;37(6):972.
Swartz RH, Stuss DT, Gao F, Black SE Independent cognitive effects of atrophy and diffuse subcortical and thalamico-cortical cerebrovascular disease in dementia. Stroke. 2008 Mar;39(3):822-30. doi: 10.1161/STROKEAHA.107.491936.
Zhu LL, Lindenberg R, Alexander MP, Schlaug G Lesion load of the corticospinal tract predicts motor impairment in chronic stroke. Stroke. 2010 May;41(5):910-5. doi: 10.1161/STROKEAHA.109.577023.
FOCAL CORTICAL ATROPHY AFTER MYOCARDIAL INTERNAL CAPSULE: CORRELATION FRACTION ANISOTROPY BEAM PYRAMID AND DISABILITY
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.